Comment
doi: 10.1002/ibd.20765.
PPARgamma agonists as a new class of effective treatment for ulcerative colitis
Affiliations
- PMID: 18798571
- DOI: 10.1002/ibd.20765
Item in Clipboard
Comment
PPARgamma agonists as a new class of effective treatment for ulcerative colitis
Inflamm Bowel Dis.
2009 Jun.
No abstract available
Comment on
-
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.Gastroenterology. 2008 Mar;134(3):688-95. doi: 10.1053/j.gastro.2007.12.012. Epub 2007 Dec 7. Gastroenterology. 2008. PMID: 18325386 Free PMC article. Clinical Trial.
Similar articles
-
Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-gamma activity.Am J Gastroenterol. 2010 Jul;105(7):1595-603. doi: 10.1038/ajg.2009.749. Epub 2010 Jan 19. Am J Gastroenterol. 2010. PMID: 20087330 Clinical Trial.
-
The Expression of the Short Isoform of Thymic Stromal Lymphopoietin in the Colon Is Regulated by the Nuclear Receptor Peroxisome Proliferator Activated Receptor-Gamma and Is Impaired during Ulcerative Colitis.Front Immunol. 2017 Sep 4;8:1052. doi: 10.3389/fimmu.2017.01052. eCollection 2017. Front Immunol. 2017. PMID: 28928735 Free PMC article.
-
Polymorphism of peroxisome proliferator-activated receptor gamma is not associated to Japanese ulcerative colitis.Hepatogastroenterology. 2008 Jan-Feb;55(81):73-5. Hepatogastroenterology. 2008. PMID: 18507082
-
[Anti-inflammatory effect of PPARgamma agonists: basics and clinical applications].Nihon Rinsho. 2010 Feb;68(2):278-83. Nihon Rinsho. 2010. PMID: 20158097 Review. Japanese.
-
Nicotine: does it have a role in the treatment of ulcerative colitis?Am J Ther. 1997 Apr;4(4):141-8. Am J Ther. 1997. PMID: 10423604 Review.
Cited by
-
Immunoregulatory mechanisms of macrophage PPAR-γ in mice with experimental inflammatory bowel disease.Mucosal Immunol. 2011 May;4(3):304-13. doi: 10.1038/mi.2010.75. Epub 2010 Nov 10. Mucosal Immunol. 2011. PMID: 21068720 Free PMC article.
-
Molecular Docking, Dynamics, and Preclinical Studies Reveal Morin Hydrate as a Potent PPARγ and Nrf2 Agonist That Mitigates Colon Inflammation.Pharmacol Res Perspect. 2025 Aug;13(4):e70132. doi: 10.1002/prp2.70132. Pharmacol Res Perspect. 2025. PMID: 40611672 Free PMC article.
-
Abscisic acid ameliorates experimental IBD by downregulating cellular adhesion molecule expression and suppressing immune cell infiltration.Clin Nutr. 2010 Dec;29(6):824-31. doi: 10.1016/j.clnu.2010.02.009. Epub 2010 Mar 16. Clin Nutr. 2010. PMID: 20236740 Free PMC article.
-
The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course.PPAR Res. 2012;2012:349469. doi: 10.1155/2012/349469. Epub 2012 Feb 14. PPAR Res. 2012. PMID: 22448164 Free PMC article.
-
Beneficial effects of THSG on acetic acid-induced experimental colitis: involvement of upregulation of PPAR-γ and inhibition of the Nf-Κb inflammatory pathway.Molecules. 2011 Oct 12;16(10):8552-68. doi: 10.3390/molecules16108552. Molecules. 2011. PMID: 21993246 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources